B LYMPHOCYTE TOLERANCE IN HEALTH AND AUTOIMMUNITY
B LYMPHOCYTE TOLERANCE IN HEALTH AND AUTOIMMUNITY
批准号:
2865273
负责人:
DAVID NEMAZEE
金额:
$18.68万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-07-01 至 2002-03-31
关键词:
B lymphocyte Escherichia coli Orthomyxoviridae antibody formation autoimmunity cross immunity gene rearrangement genetic transduction genetically modified animals immune tolerance /unresponsiveness immunoglobulin genes immunologic memory laboratory mouse leukocyte activation /transformation microorganism antigen molecular cloning tissue /cell culture
中文摘要
描述(改编自调查者摘要):这是一项研究
研究B淋巴细胞耐受性的项目资助。调查员和其他人
已经证明,在没有T细胞帮助的情况下,B细胞可以有效地
被容忍了。尽管这些研究帮助证明了B细胞
容忍可以而且确实是通过许多机制发生的,这种积累
关于B细胞耐受性的知识使一组新的
问题。与从最近的容忍中得出的一般性结论形成对比
研究表明,也有大量证据表明,自身反应性B-
细胞不能只存在于外围,特别是在B-1
但这种自我反应性实际上可以增加它们的丰度。一个
进一步反驳了多价抗原引起B-
在没有T细胞帮助的情况下细胞删除是T-
独立的抗体反应,其中高度多价的抗原
缺乏T细胞表位可有效刺激抗体反应。最后,
研究人员在B细胞耐受性方面的信息并不真正允许
以预测B细胞耐受规则在挑战过程中如何变化
有交叉反应的抗原。换句话说,他们不知道B细胞
免疫反应(如感染)中的自身反应是正常的,
也不知道这种自动反应在多大程度上是在
感染以及这些机制中是否有任何机制存在缺陷的自身免疫倾向
老鼠。了解区分积极的规则是很重要的
来自消极选择。在这份申请中,调查员的建议
B细胞在免疫消退期间和解体后的耐受性
对外来抗原的反应。为了实现这一目标,他们利用
抗体结合部位的简并性
给免疫系统带来了抗原模仿的问题。怎么了?
免疫系统维持自我与非自我的区别
已在此应用程序中寻址。这些研究的长期目标是
了解如何避免B细胞自身反应并确定发生了什么
自动豁免权是错误的。
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): This is a research
project grant to study B lymphocyte tolerance. The investigator and others
have shown that in the absence of T-cell help, B-cells can be efficiently
tolerized. Although these studies have helped demonstrated that B-cell
tolerance can and does occur by a number of mechanisms, this accumulating
knowledge about B-cell tolerance has brought into focus a new set of
questions. In contrast to the generalities concluded from recent tolerance
studies, there also exists a body of evidence arguing that autoreactive B-
cells cannot only persist in the periphery, particularly in the B-1
subset., but that self-reactivity can actually enhance their abundance. A
further contradiction to the concept that multivalent antigens elicit B-
cell deletion in the absence of T-cell help is the phenomenon of T-
independent antibody responses, in which highly multivalent antigens that
lack T-cell epitopes efficiently stimulate antibody responses. Finally,
the investigator's information in B-cell tolerance does not really permit
them to predict how the rules of B-cell tolerance change during challenge
with cross reactive antigens. In other words, they do not know if B-cell
autoreactivity during an immune response such as infection is the norm,
nor is it known to what extent this autoreactivity is resolved after
infection and if any of these mechanisms are defective in autoimmune-prone
mice. It is important to understand the rules that distinguish positive
from negative selection. In this application, the investigator's propose
to characterize B-cell tolerance during and upon resolution of an immune
response to foreign antigen. To accomplish this aim, they take advantage
of a system in which the degeneracy of the antibody combining site
presents a problem of antigenic mimicry to the immune system. How the
immune system maintains the distinction between self and non-self will be
addressed in this application. The long term goal of these studies is to
understand how B-cell autoreactivity is avoided and to determine what goes
wrong in autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of PLD3 in nucleic acid recognition and brain function
-
批准号:10525053
-
项目类别:
-
资助金额:$133.13万
-
财政年份:2022
-
负责人:DAVID NEMAZEE
-
依托单位:
Role of PLD3 in nucleic acid recognition and brain function
-
批准号:10388543
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2021
-
负责人:DAVID NEMAZEE
-
依托单位:
Immune Tolerance in Non-Clonal Immune Systems
-
批准号:9546043
-
项目类别:
-
资助金额:$53.47万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:10190786
-
项目类别:
-
资助金额:$67.91万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:10436822
-
项目类别:
-
资助金额:$67.91万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:10405523
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
-
批准号:10159204
-
项目类别:
-
资助金额:$64.94万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:9973126
-
项目类别:
-
资助金额:$67.91万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:9810386
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:10630110
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:10159840
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
-
批准号:10405534
-
项目类别:
-
资助金额:$64.94万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:10641828
-
项目类别:
-
资助金额:$63.53万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Germline targeting influenza immunogens
-
批准号:9363697
-
项目类别:
-
资助金额:$141.77万
-
财政年份:2017
-
负责人:DAVID NEMAZEE
-
依托单位:
Germline targeting influenza immunogens
-
批准号:10226016
-
项目类别:
-
资助金额:$139.41万
-
财政年份:2017
-
负责人:DAVID NEMAZEE
-
依托单位:
Designing and optimizing candidate HIV vaccines and boosting protocols
-
批准号:10053304
-
项目类别:
-
资助金额:$96.23万
-
财政年份:2016
-
负责人:DAVID NEMAZEE
-
依托单位:
Designing and optimizing candidate HIV vaccines and boosting protocols
-
批准号:9246148
-
项目类别:
-
资助金额:$96.23万
-
财政年份:2016
-
负责人:DAVID NEMAZEE
-
依托单位:
Analysis of the immunological role of Phospholipase D4
-
批准号:8495932
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2012
-
负责人:DAVID NEMAZEE
-
依托单位:
Analysis of the immunological role of Phospholipase D4
-
批准号:8356431
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2012
-
负责人:DAVID NEMAZEE
-
依托单位:
Functional analysis of Phospholipase D4
-
批准号:7871481
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2009
-
负责人:DAVID NEMAZEE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
重编程L-苏氨酸生产菌株Escherichia coli THRH高效合成L-异亮氨酸的底盘菌株设计与构建
-
批准号:22508213
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:赵振强
-
依托单位:
肠道Escherichia coli BW25113增殖调控C1GALT1介导IgA肾病发生的作用与机制
-
批准号:82470735
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2024
-
负责人:赵晋
-
依托单位:
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: